Increasing unusual option volume: EOLS MXWL PAGP PBI PKI ARRY ASND NCR AMG MMC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. SAP
8. LRCX
9. MRK
10. LVS

Go back to Increasing unusual option volume: EOLS MXWL PAGP PBI PKI ARRY ASND NCR AMG MMC

Array Biopharma (ARRY) Tops Q2 EPS by 10c, Revenues Beat

February 5, 2019 8:02 AM EST

Array Biopharma (NASDAQ: ARRY) reported Q2 EPS of ($0.05), $0.10 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $82.5 million versus the consensus estimate of $52.45 million.

Second Quarter of Fiscal 2019 Compared to First Quarter of Fiscal 2019

Net Product Sales for BRAFTOVI + MEKTOVI for the second quarter of fiscal 2019 was $22.7 million, compared to $14.0 million for the first quarter of fiscal 2019.Total Revenue for the second quarter of fiscal 2019 was $82.5 million, compared to $56.9 million for the prior quarter. The increase was primarily due to higher product sales and... More